AIkido Pharma, Inc.
(NASDAQ : SPEX)

( )
SPEX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -13.49%265.330.0%$3803.52m
BNTXBioNTech SE -18.67%279.830.0%$1221.54m
NVAXNovavax, Inc. -11.60%141.8678.2%$678.26m
AMGNAmgen, Inc. 3.14%208.791.4%$636.09m
GILDGilead Sciences, Inc. -0.09%69.501.0%$509.20m
LGVNLongeveron Inc. 0.65%20.250.0%$468.87m
VRTXVertex Pharmaceuticals, Inc. 0.61%205.061.9%$451.31m
REGNRegeneron Pharmaceuticals, Inc. -1.60%625.002.7%$399.60m
ILMNIllumina, Inc. 1.26%351.653.3%$324.62m
SNSSSunesis Pharmaceuticals, Inc. 2.68%4.210.7%$294.29m
BIIBBiogen, Inc. 0.09%224.111.8%$281.34m
SGENSeagen Inc. -3.14%146.015.8%$152.04m
INCYIncyte Corp. -1.17%65.012.4%$146.25m
EXASEXACT Sciences Corp. 5.55%80.8418.0%$141.11m
BMRNBioMarin Pharmaceutical, Inc. 1.56%84.244.2%$134.04m

Company Profile

AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.